Response to Kujawa et al. letter-to-the-editor

Comment

. 2006 May;84(1):172-3.

doi: 10.1016/j.schres.2005.11.010. Epub 2006 Mar 24.

Comment

Gopalan Sethuraman et al. Schizophr Res. 2006 May.

. 2006 May;84(1):172-3.

doi: 10.1016/j.schres.2005.11.010. Epub 2006 Mar 24.

No abstract available

Comment on

Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L, Ji Z, Koch G, Hamer RM. Lieberman JA, et al. Neuropsychopharmacology. 2003 May;28(5):995-1003. doi: 10.1038/sj.npp.1300157. Epub 2003 Mar 26. Neuropsychopharmacology. 2003. PMID: 12700715 Clinical Trial.
Remission in schizophrenia: proposed criteria and rationale for consensus.
Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Andreasen NC, et al. Am J Psychiatry. 2005 Mar;162(3):441-9. doi: 10.1176/appi.ajp.162.3.441. Am J Psychiatry. 2005. PMID: 15741458 Review.